---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-014467"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T04:42:55.063895+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q2 adjusted EPS $0.47 vs $0.41 YoY; revenue up 2.7%; FY22 EBITDA outlook reaffirmed

## Summary
- GAAP EPS $0.36 flat YoY; adjusted EPS $0.47 vs $0.41 on revenue of $486M (+2.7%).
- Same-unit revenue down 1.3%; volume up 0.6% offset by reimbursement decline of 1.9%.
- Adjusted EBITDA flat at $65.6M; FY22 outlook reaffirmed at $260-270M.
- Repurchased 3.3M shares for $64.4M in Q2; total debt $800M after refinancing.
- Interest expense fell to $8.4M from $16.9M due to Q1 refinancing.

## SEC filing metadata
- accession: 0000950170-22-014467
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017022014467/0000950170-22-014467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017022014467/md-20220804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-014467
- JSON: https://secwatch.observer/filing/0000950170-22-014467.json
- Plain text: https://secwatch.observer/filing/0000950170-22-014467.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.